PathoQuest is a global CRO specializing in Next Generation Sequencing (NGS)-based biosafety testing through its iDTECT® platform. Offering GMP-compliant assays for viral safety and genetic characterization of cell and gene therapies, vaccines, and biologics, PathoQuest delivers faster, safer, and animal-free Quality Control (QC) testing. With laboratories in Paris (France) and Wayne, PA (USA), the company supports the biopharma industry worldwide. Learn more at www.pathoquest.com.